This case report describes the clinical course, diagnosis, and management of a premenopausal woman with a history of estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (EBC) who developed severe thrombocytopenia. Here, ERBB2 is linked to Thrombocytopenia.